Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,070 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
KRN5500, a spicamycin derivative, exerts anti-myeloma effects through impairing both myeloma cells and osteoclasts.
Miki H, Ozaki S, Nakamura S, Oda A, Amou H, Ikegame A, Watanabe K, Hiasa M, Cui Q, Harada T, Fujii S, Nakano A, Kagawa K, Takeuchi K, Yata K, Sakai A, Abe M, Matsumoto T. Miki H, et al. Among authors: cui q. Br J Haematol. 2011 Nov;155(3):328-39. doi: 10.1111/j.1365-2141.2011.08844.x. Epub 2011 Sep 9. Br J Haematol. 2011. PMID: 21902681 Free article.
Targeting myeloma-osteoclast interaction with Vγ9Vδ2 T cells.
Cui Q, Shibata H, Oda A, Amou H, Nakano A, Yata K, Hiasa M, Watanabe K, Nakamura S, Miki H, Harada T, Fujii S, Kagawa K, Takeuchi K, Ozaki S, Matsumoto T, Abe M. Cui Q, et al. Int J Hematol. 2011 Jul;94(1):63-70. doi: 10.1007/s12185-011-0885-9. Epub 2011 Jun 23. Int J Hematol. 2011. PMID: 21698356
Expansion of Th1-like Vγ9Vδ2T cells by new-generation IMiDs, lenalidomide and pomalidomide, in combination with zoledronic acid.
Harada T, Miki H, Cui Q, Oda A, Amachi R, Teramachi J, Bat-Erdene A, Sogabe K, Iwasa M, Fujii S, Nakamura S, Kagawa K, Yoshida S, Endo I, Aihara K, Ozaki S, Matsumoto T, Abe M. Harada T, et al. Among authors: cui q. Leukemia. 2017 Jan;31(1):258-262. doi: 10.1038/leu.2016.273. Epub 2016 Oct 4. Leukemia. 2017. PMID: 27698446 No abstract available.
Glycolysis inhibition inactivates ABC transporters to restore drug sensitivity in malignant cells.
Nakano A, Tsuji D, Miki H, Cui Q, El Sayed SM, Ikegame A, Oda A, Amou H, Nakamura S, Harada T, Fujii S, Kagawa K, Takeuchi K, Sakai A, Ozaki S, Okano K, Nakamura T, Itoh K, Matsumoto T, Abe M. Nakano A, et al. Among authors: cui q. PLoS One. 2011;6(11):e27222. doi: 10.1371/journal.pone.0027222. Epub 2011 Nov 2. PLoS One. 2011. PMID: 22073292 Free PMC article.
Reveromycin A, a novel acid-seeking agent, ameliorates bone destruction and tumor growth in multiple myeloma.
Watanabe K, Bat-Erdene A, Tenshin H, Cui Q, Teramachi J, Hiasa M, Oda A, Harada T, Miki H, Sogabe K, Oura M, Sumitani R, Mitsui Y, Endo I, Tanaka E, Kawatani M, Osada H, Matsumoto T, Abe M. Watanabe K, et al. Among authors: cui q. Haematologica. 2021 Apr 1;106(4):1172-1177. doi: 10.3324/haematol.2019.244418. Haematologica. 2021. PMID: 32586903 Free PMC article. No abstract available.
3,070 results